SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

Blood sugar management

News headlines

Companies must walk fine line when bringing a supplement to market in US that is a drug elsewhere

A company known as PharmaRoth Labs had to absorb a setback recently when it announced that FDA had objected to a New Dietary Ingredient notification the company filed on its Sucanon ingredient. The incident points out the potential pitfalls of bringing to the US market a dietary supplement that is sold as a drug elsewhere.

'The first such patented drinks ever been made in the world': Hydro One CEO Sammy Nasrollahi

Diabetes busting cinnamon: Hydro One drinks score US patent triumph

Hydro One Beverages has won a US patent for healthy soft drinks line REVd that uses a special cinnamon extract to tackle problems associated with high blood sugar such as diabetes and hyperglycemia.

Gut microbiota ‘networks’ may play a role in autoimmunity and type 1 diabetes risk

The way in which our gut bacteria interact with each other may have vital implications for the risk of developing type 1 diabetes, according to new research.

Lozenges show potential as novel resveratrol delivery system: Study

Delivering resveratrol via a lozenge that dissolves in the mouth may increase the absorption of the red wine compound more than other dosage forms for absorption in the gut, according to new data.

Proposed changes to supplement labels could cause many products to be reformulated

The new levels of nutrients specified will be the prime impact of FDA’s proposed changes on the labels for foods and supplements for the dietary supplement industry, experts agree.

Research supports bergamot's benefit in fatty liver disease, manufacturer says

Natural Health Solutions says new research confirms the benefits of its BergaMet supplement, a highly concentrated extract of the Calabrian bergamot fruit, has benefits for consumers who show signs of nonalcoholic fatty liver disease (NAFLD).

Data shows 'cobiotic' modulates glucose response in diabetic and pre diabetic subjects

Microbiome Therapeutics, a startup based in Broomfield, CO, has developed a technology that it says can significantly shift the makeup of the gut microflora in prediabetic patients and those with type 2 diabetes.  Prelimary data shows the company’s flaghsip product called NM504 improved blood glucose response in those patients.

Multi-platform automated program aims to help pre-diabetics manage conditions

A company based in Berkeley, CA has launched a new interactive program for mobile devices to help prediabetic patients avoid trending over into full-blown diabetes.  The program, called Alive PD, is the first of its kind to focus on diabetes prevention, according to the developers.

Bioactives American brings first GRAS-affirmed salacia oblonga extract to market

Bioactives American Corporation has brought to market what the company calls the first GRAS version of a salacia oblonga ingredient for blood sugar management.

Register now for our free online event

The latest developments in healthy and functional lipids: Exclusive online event

Want the latest market information, and scientific insights in for the nutritional lipids and oils market? Then join us at our free online event, Nutritional Lipids and Oils 2014.

Literature supports fenugreek’s blood sugar management potential: Meta-analysis

Daily supplements of fenugreek may effectively help manage blood sugar levels in people with diabetes, according to a meta-analysis of 10 clinical trials.

Special edition: Polyphenols

Polyphenol science needs to catch up to better inform regulators and consumers, say experts

A paradigm shift is needed in the study of polyphenols to better understand the bioavailability, bio-activity, and the role of the gut microbiota in polyphenol metabolism and health benefits, say experts from academia and industry.

Special edition: Polyphenols

Nano emulsion system seeks to protect polyphenols from overly rapid alteration in liver

Bioavailability has always been the achilles heel of polyphenols.  Scientist felt they had a good handle on why these molecules exerted their health effects, but had a far less clear view of how to get them to the locations in the body where they could do the most good.  The answer for many years was a practice of putting in overages in formulations, an approach that was not very tidy, and potentially more expensive than it needed to be.

Special edition: Polyphenols

Global tea polyphenols market set to hit $368 million by 2020

Tea polyphenols are poised to enjoy strong growth over the next decade, with a new market report calling for the global market in the ingredients to hit $368 million by 2020.  That makes sense to observers, who say the popularity of tea, green tea in particular, boosts awareness of the ingredients derived from the plant.

Special edition: Polyphenols

The big challenges in polyphenols: Providing credible evidence and a quality supply chain

With surging interest in the potential health benefits of polyphenols around the globe, experts suggest that there are still some major sticking points in the polyphenol success story.

Increased intake of long-chain omega-3 may reduce diabetes risk: Study

High serum concentrations of long-chain omega-3 fatty acids could help to reduce the risk of developing type 2 diabetes by up to a third, according to new population data.

Flavonoid-rich diet may reduce risk of type 2 diabetes: Study

High consumption of flavonoid-rich foods may be associated with a lowering the risk of developing type 2 diabetes by improving blood sugar management, say researchers.

EU health claim for inulin has more immediate importance in the US: Beneo

Attaining a positive health claims opinion from the European Food Safety Authority (EFSA) may be of more importance immediately in the US than in the EU, says leading inulin supplier Beneo.

‘Opening doors’: Whole grape extracts support cardiovascular health and antioxidant activity

Daily intake of a whole grape extract may improve antioxidant levels, and improve cholesterol levels, says the first North American study to report such measures.

InterHealth acquired by private equity firm

Specialty ingredient supplier InterHealth Nutraceuticals has been acquired by private equity firm Kainos Capital, the company announced Tuesday.  Details of the deal were not disclosed.

Related News

Product Innovation